The future of heart disease treatment may change after a study found that a common post-heart attack medication may not be as ...

Pharmacists Corewell Health transforming heart failure care by accelerating medication optimization and improving patient outcomes in Michigan.

Research shows semaglutide — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people ...

Clinicians gathered in Houston, Texas, to examine how newer drug options are reshaping cardiometabolic care and how ...

What would you do if I told you there is drug widely available without prescription that kills almost 500 Americans every day ...

Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and GI oncology diseases, ...

Participants exposed critical gaps in the diagnosis, treatment, and coordination of care for patients with heart failure with preserved ejection fraction and charted a path forward.

Doctor-assisted death is portrayed as a rapid, peaceful and comfortable death, yet potential complications are a recognized ...

A common painkiller widely used across the UK could pose a risk to heart health ...

A simple blood test has revealed one in five people living with overweight and ‘unhealthy fat’ could have a heart attack in ...

Euphoria’s finale does a major disservice to its beating heart.

The findings demonstrate that aprocitentan may help reduce the risk of kidney disease progression, cardiovascular events, and ...